Cathepsin S generates soluble CX3CL1 (fractalkine) in vascular smooth muscle cells

Biol Chem. 2013 Oct;394(10):1349-52. doi: 10.1515/hsz-2013-0189.

Abstract

CX3CL1 chemokine (fractalkine) is highly expressed by vascular smooth muscle cells (VSMCs) in atherosclerotic lesions. Its membrane-bound form promotes cell-cell interactions, whereas the soluble form induces chemotaxis of CX3CR1- expressing leukocytes. We show that the cysteine protease cathepsin S, expressed by VSMCs, is able to cleave membrane-anchored CX3CL1, releasing a 55-kDa fragment to the medium, thus regulating the adhesion of VSMCs and the capture of monocytes to the sites of atherogenesis. Moreover, strong co-localization of cathepsin S and CX3CL1 with a recycling endosome marker Rab11a suggests a processing of CX3CL1 in recycling endosomes during its redistribution to the plasma membrane.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cathepsins / metabolism*
  • Cell Adhesion
  • Chemokine CX3CL1 / genetics
  • Chemokine CX3CL1 / metabolism*
  • Flow Cytometry
  • Humans
  • Muscle, Smooth, Vascular / enzymology
  • Muscle, Smooth, Vascular / metabolism*
  • Peptide Fragments / genetics
  • Peptide Fragments / metabolism

Substances

  • Chemokine CX3CL1
  • Peptide Fragments
  • Cathepsins
  • cathepsin S